Cambridge Innovation Capital (CIC), VC Farm is investing in the British High-Belive Diptech and Life Sciences Companies, announced that they are committing at least $ 1 million Cambridge UniversityThe
This investment formed the Cambridge Ecosystem to invest in the Cambridge University of Cambridge spinouts to invest in the central € 288 million initial phase of Venture Fund, Fund III.
Andrew WilliamsonManaging Partner, CIC says: “Cambridge is at the top of the innovation in Deep Tech and Life Sciences. Our new EIR program is the educators and researchers we will provide 100 million access to the Cambridge University of Cambridge spinouts as they continue to develop breakthrough technology. This expansion of CIC’s long -lasting partnership with the University of Cambridge by providing unique access to the University Academics and Research will help support the UK’s economic growth by developing the next generation of world -class agenciesThe “
Established in 2013, CIC This is an established VC firm that says it “One of the world’s most influential science and technology ecosystems“, Embeding on the UK’s Innovation Ecosystem with a twelve year track record for identifying, supporting and exiting science-powered companies, and CICs work closely with its investors, including main pension funds and family offices.
The CIC operates over $ 693 million capital and invests in cancer therapy, genomic diagnostics and surgical robotics, from AI, semiconductor and quantum computing throughout diptech and life science. Notable portfolio agencies include CMR surgical, practical and riverlen.
Cambridge contributes more than spinouts € 26 billion In the Economy of the UK. The university has also produced Maximum number Unicorn agencies of any European ecosystem. Notable successes include world-renowned technology companies like Darktress, ARM and Akbam.
Dr. Diermoid O’BrienPro-Vis-Chancellor for the innovation of the University of Cambridge says: “In 2024, the University of Cambridge built more spinout agencies than any other university. It created the most unicorn of any European ecosystem and every year, $ 23 billion associated with research and commercialization has produced economic interest. We promise to determines to make investments more and more by making investments in our spinout agencies like new EIR programs and partners like Cambridge Innovation CapitalThe “
A new entrepreneur (EIR) program is launching with the university to support the IP with the CIC’s promise, to partnership with the CIC University, to identify the possibility of commercialization and to support the academic founders to support the university. In conjunction with experienced diptech and life science executives, many of whom have earned significant exit with their previous businesses, including academics and high-level IP, will aim to increase the number of quality spinouts and to accelerate the way to sustainable commercialization of technology.
The EIR program, which will maintain the Rolling Cohort up to six EIRS, is the latest project to support spinouts from the university. The Cambridge University has also launched the founding program to support the creation of a new company; Technology Investment Fund (TIF), a new proof of the concept fund to enable world -class research and enable rapid commercialization; And $ 115 million to support the growing investment of university investment in spinouts is an additional $ 34 million capital for the AOM Cambridge Enterprise Venture (CEV) fund.
Companies created within the EIR program may access new funds to support development from the beginning through proof-off-concept of early stages.
Recent examples of university success stories that will create this EIR program: It contains:
- Riverlen – Former DAMTP Academic with CIC and CEV support, a quantum computing company founded by Dr. Steve Brialey. It has collected more than $ 105 million to establish a top position in quantum error correcting.
- T-Therapeutics-A therapeutics company, a TCR discovery engine founded by Prof. Alan Bradley, which can unlock the energy of T cells for cancer and autoimmune disease. Based on the University IP, the company has raised money from CEV, CIC and institutional investors.
- Cambridge Gan Devices (CGD) – 2017 Postdok Business Plan Competition Dr. Georgio Longberto and Professor Florin Woodria founded CGD after winning. The company has designed GN Power Electronics devices to convert energy skilled electricity and collected more than $ 43 million from CEV, CIC and various institutional investors.
This fund will want to take advantage of the commercial possibilities of innovating science and technology developed by Cambridge researchers and will follow a recent initiative from the university designed to support entrepreneurial academics. These include a four -square -foot high -tech development plan in Cambridge West and a new innovative center of Central Cambridge to host spinouts, startups and entrepreneurs.
[publish_date
